Dr. Stacie Jones is a co-author and site primary investigator (PI) at the Arkansas Children’s Research Institute (ACRI) for a phase 3 trial of epicutaneous immunotherapy in toddlers with peanut allergy.
The abstract for the findings states, “No approved treatment for peanut allergy exists for children younger than 4 years of age, and the efficacy and safety of epicutaneous immunotherapy with a peanut patch in toddlers with peanut allergy are unknown.”
The group’s findings were published in the New England Journal of Medicine.